248 related articles for article (PubMed ID: 16305513)
41. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L
J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170
[TBL] [Abstract][Full Text] [Related]
42. Ubiquitin-proteasome pathway mediates degradation of APH-1.
He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
[TBL] [Abstract][Full Text] [Related]
43. Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain.
McFadden T; Devulapalli RK; Jarome TJ
J Vis Exp; 2019 May; (147):. PubMed ID: 31180360
[TBL] [Abstract][Full Text] [Related]
44. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
45. Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.
Desai S; Juncker M; Kim C
Exp Biol Med (Maywood); 2018 Mar; 243(6):554-562. PubMed ID: 29316798
[TBL] [Abstract][Full Text] [Related]
46. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
Staszczak M
Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
[TBL] [Abstract][Full Text] [Related]
47. The ubiquitin-proteasome pathway and synaptic plasticity.
Hegde AN
Learn Mem; 2010 Jul; 17(7):314-27. PubMed ID: 20566674
[TBL] [Abstract][Full Text] [Related]
48. The role of the ubiquitin-proteasome system in kidney diseases.
Fukasawa H
Clin Exp Nephrol; 2012 Aug; 16(4):507-17. PubMed ID: 22684356
[TBL] [Abstract][Full Text] [Related]
49. Reduced free ubiquitin levels and proteasome activity in cultured neurons and brain tissues treated with amyloid beta aggregates.
Park CW; Jung BK; Ryu KY
Mol Brain; 2020 Jun; 13(1):89. PubMed ID: 32513213
[TBL] [Abstract][Full Text] [Related]
50. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.
Graham SH; Liu H
Ageing Res Rev; 2017 Mar; 34():30-38. PubMed ID: 27702698
[TBL] [Abstract][Full Text] [Related]
51. Regulating the ubiquitin/proteasome pathway via cAMP-signaling: neuroprotective potential.
Huang H; Wang H; Figueiredo-Pereira ME
Cell Biochem Biophys; 2013 Sep; 67(1):55-66. PubMed ID: 23686612
[TBL] [Abstract][Full Text] [Related]
52. The ubiquitin-proteasome system and proteasome inhibitors in central nervous system diseases.
Shah IM; Di Napoli M
Cardiovasc Hematol Disord Drug Targets; 2007 Dec; 7(4):250-73. PubMed ID: 18220725
[TBL] [Abstract][Full Text] [Related]
53. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
von Mikecz A; Chen M; Rockel T; Scharf A
Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
[TBL] [Abstract][Full Text] [Related]
54. Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases.
Golab J; Bauer TM; Daniel V; Naujokat C
Clin Chim Acta; 2004 Feb; 340(1-2):27-40. PubMed ID: 14734194
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide approaches to systematically identify substrates of the ubiquitin-proteasome pathway.
Liu C; Choe V; Rao H
Trends Biotechnol; 2010 Sep; 28(9):461-7. PubMed ID: 20637515
[TBL] [Abstract][Full Text] [Related]
56. Chronic cerebral hypoperfusion in rats causes proteasome dysfunction and aggregation of ubiquitinated proteins.
Hai J; Lin Q; Su SH; Zhang L; Wan JF; Lu Y
Brain Res; 2011 Feb; 1374():73-81. PubMed ID: 21167821
[TBL] [Abstract][Full Text] [Related]
57. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
[TBL] [Abstract][Full Text] [Related]
58. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
Schmitt HP
Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
[TBL] [Abstract][Full Text] [Related]
59. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
Ciechanover A
Hematology Am Soc Hematol Educ Program; 2006; ():1-12, 505-6. PubMed ID: 17124032
[TBL] [Abstract][Full Text] [Related]
60. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
Burger AM; Seth AK
Eur J Cancer; 2004 Oct; 40(15):2217-29. PubMed ID: 15454246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
